Baljit Singh Selected Research

Biopex

1/2022	Cumulative 5-year Results of a Randomized Controlled Trial Comparing Biological Mesh With Primary Perineal Wound Closure After Extralevator Abdominoperineal Resection (BIOPEX-study).
1/2017	Biological Mesh Closure of the Pelvic Floor After Extralevator Abdominoperineal Resection for Rectal Cancer: A Multicenter Randomized Controlled Trial (the BIOPEX-study).
8/2014	Randomized controlled multicentre study comparing biological mesh closure of the pelvic floor with primary perineal wound closure after extralevator abdominoperineal resection for rectal cancer (BIOPEX-study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Baljit Singh Research Topics

Disease

42	Neoplasms (Cancer) 01/2022 - 01/2002
33	Breast Neoplasms (Breast Cancer) 01/2019 - 05/2002
31	Pneumonia (Pneumonitis) 06/2022 - 05/2003
21	Inflammation (Inflammations) 06/2022 - 02/2004
13	Wounds and Injuries (Trauma) 01/2022 - 04/2011
8	Carcinogenesis 02/2015 - 03/2003
5	Rectal Neoplasms (Rectal Cancer) 01/2022 - 08/2014
5	Pathologic Complete Response 01/2022 - 02/2008
5	Noninfiltrating Intraductal Carcinoma (DCIS) 09/2017 - 02/2005
5	Ulcerative Colitis 01/2016 - 04/2007
5	Adenocarcinoma 01/2015 - 01/2002
5	Sepsis (Septicemia) 11/2014 - 10/2005
4	Triple Negative Breast Neoplasms 01/2022 - 01/2013
4	Hernia (Hernias) 01/2022 - 08/2014
4	COVID-19 09/2020 - 01/2020
4	Heart Arrest (Cardiac Arrest) 05/2020 - 11/2017
4	Infections 05/2020 - 05/2004
4	Carcinoma (Carcinomatosis) 11/2017 - 06/2008
4	Endotoxemia 11/2014 - 07/2005
4	Neoplasm Metastasis (Metastasis) 11/2014 - 10/2004
3	Respiratory Hypersensitivity 06/2022 - 06/2005
3	Asthma (Bronchial Asthma) 06/2022 - 03/2012
3	Acute Lung Injury 07/2021 - 01/2014
3	Diarrhea 03/2020 - 04/2007
3	Adenoma (Adenomas) 01/2018 - 01/2015
3	Lung Diseases (Lung Disease) 01/2018 - 02/2011
3	Reperfusion Injury 01/2018 - 03/2014
3	Pain (Aches) 01/2017 - 11/2002
3	Lung Injury 07/2016 - 01/2010
3	Disease Progression 01/2016 - 12/2007
3	Colorectal Neoplasms (Colorectal Cancer) 02/2015 - 06/2012
3	Hyperplasia 11/2014 - 02/2005
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2022 - 04/2007
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 03/2012
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2021 - 04/2021
2	Ischemia 01/2021 - 10/2005
2	Acute Necrotizing Pancreatitis 05/2020 - 10/2019
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 05/2020 - 01/2014
2	Neutropenia 06/2018 - 01/2015
2	Diverticulitis 02/2017 - 09/2009

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 06/2022 - 04/2002
16	Pharmaceutical PreparationsIBA 03/2020 - 08/2008
15	HydrogelsIBA 03/2020 - 08/2008
12	EndotoxinsIBA 05/2021 - 01/2004
10	Biomarkers (Surrogate Marker)IBA 10/2018 - 11/2004
8	CytokinesIBA 06/2022 - 01/2008
7	Biological ProductsIBA 01/2022 - 10/2003
7	LipopolysaccharidesIBA 07/2021 - 07/2005
7	Polysaccharides (Glycans)IBA 03/2020 - 04/2007
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2003
6	Anti-Bacterial Agents (Antibiotics)IBA 03/2020 - 04/2010
5	Hormones (Hormone)IBA 01/2013 - 08/2003
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2003
4	Messenger RNA (mRNA)IBA 01/2022 - 06/2012
4	Estrogen ReceptorsIBA 01/2019 - 08/2003
4	AntioxidantsIBA 06/2017 - 11/2013
4	human ERBB2 proteinIBA 02/2016 - 09/2012
4	Estrogens (Estrogen)FDA Link 01/2016 - 08/2003
4	MicroRNAs (MicroRNA)IBA 02/2015 - 06/2012
4	Anesthetics (Anesthetic Agents)IBA 11/2014 - 01/2010
4	IntegrinsIBA 04/2012 - 05/2004
3	BiopexIBA 01/2022 - 08/2014
3	Gum Arabic (Acacia, Gum)FDA Link 06/2017 - 11/2013
3	Oxygen (Dioxygen)IBA 11/2016 - 05/2012
3	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 03/2004
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2016 - 01/2006
3	Estrogen Receptor alphaIBA 01/2016 - 02/2005
3	AngiostatinsIBA 01/2014 - 10/2005
3	Androgen Receptors (Androgen Receptor)IBA 01/2013 - 12/2010
3	Psyllium (Metamucil)IBA 04/2012 - 04/2007
3	Tamoxifen FDA LinkGeneric 03/2011 - 10/2003
3	Peptides (Polypeptides)IBA 03/2011 - 12/2007
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2007 - 02/2004
3	matriptaseIBA 08/2003 - 04/2002
2	Methacholine Chloride (Methacholine)FDA Link 06/2022 - 06/2005
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 01/2015
2	Bevacizumab (Avastin)FDA Link 01/2022 - 01/2015
2	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 01/2015
2	2,4-Dichlorophenoxyacetic Acid (2,4 Dichlorophenoxyacetic Acid)IBA 05/2021 - 04/2021
2	SelectinsIBA 02/2021 - 12/2007
2	AerosolsIBA 05/2020 - 04/2005
2	Atrial Natriuretic Factor (ANF)IBA 05/2020 - 10/2019
2	PolymersIBA 03/2020 - 01/2017
2	EnzymesIBA 09/2019 - 10/2005
2	AntigensIBA 06/2018 - 07/2011
2	Tumor Biomarkers (Tumor Markers)IBA 01/2018 - 09/2012
2	Indicators and Reagents (Reagents)IBA 01/2018 - 01/2002
2	Hematoxylin (Haematoxylon)IBA 09/2017 - 03/2017
2	Eosine Yellowish-(YS) (Eosin)IBA 09/2017 - 03/2017
2	von Willebrand FactorIBA 03/2017 - 10/2010
2	Ciprofloxacin (Cipro)FDA LinkGeneric 02/2017 - 09/2009
2	Lidocaine (Xylocaine)FDA LinkGeneric 01/2017 - 03/2014
2	Gentamicins (Gentamicin)FDA LinkGeneric 01/2017 - 11/2013
2	carboxypolymethyleneIBA 01/2017 - 11/2013

Therapy/Procedure

11	Therapeutics 01/2019 - 10/2003
10	Drug Therapy (Chemotherapy) 03/2020 - 01/2003
9	Neoadjuvant Therapy 01/2022 - 01/2003
5	Proctectomy 01/2022 - 08/2014
5	Radiotherapy 01/2022 - 12/2010
5	Cardiopulmonary Resuscitation (CPR) 09/2020 - 11/2017